5 Key Takeaways

• 1

  A randomized clinical trial found that personalized recommendations for AKI did not significantly reduce worsening kidney injury, dialysis, or mortality.

• 2

  The study involved 4,003 hospitalized patients with AKI, with a median age of 72 years and various comorbidities.

• 3

  The intervention group had a higher implementation rate of recommendations (33.8%) compared to usual care (24.3%) within 24 hours.

• 4

  No significant differences were observed between intervention and usual care groups for AKI progression, mortality, or dialysis initiation.

• 5

  The median length of stay was similar between groups, with no statistically significant differences in peak AKI stage distribution.